Adenocarcinoma of the Gastroesophageal Junction: Influence of Esophageal Resection Margin and Operative Approach on Outcome

Objective:To determine whether the length of esophageal resection or the operative approach influences outcome for patients with adenocarcinoma of the gastroesophageal junction (GEJ). Summary Background Data:While R0 resection remains the mainstay of curative treatment of patients with GEJ cancer, the optimal length of esophageal resection remains controversial. Methods:Patients with Siewert I, II, or III adenocarcinoma who underwent complete gross resection without neoadjuvant therapy were identified from a prospectively maintained database. Proximal margin lengths were recorded ex vivo as the distance from the gross tumor edge to the esophageal transection line. Operative approaches were grouped into gastrectomy (limited esophagectomy) or esophagectomy (extended esophagectomy). Results:From 1985 through 2003, 505 patients underwent R0/R1 gastrectomy (n = 153) or esophagectomy (n = 352) without neoadjuvant treatment. There were no differences in R1 resection rate, number of nodes examined or operative mortality between gastrectomy and esophagectomy. Univariate analysis found >3.8 cm to be the ex vivo proximal margin length (approximately 5 cm in situ) most predictive of improved survival. Multivariable analysis in patients who underwent R0 resection with ≥15 lymph nodes examined (n = 275) found the number of positive lymph nodes, T stage, tumor grade, and ex vivo proximal margin length >3.8 cm to be independent prognostic factors. Subset analysis found that the benefit associated with >3.8 cm margin was limited to patients with T2 or greater tumors and ≤6 positive lymph nodes. Conclusions:In patients not receiving neoadjuvant therapy, the goal for patients with adenocarcinoma of the GEJ should be R0 resection including at least 15 lymph nodes, preferably with 5 cm of grossly normal in situ proximal esophagus for those with ≤6 positive lymph nodes. The operative approach may be individualized to achieve these goals.

[1]  Y. Tachimori,et al.  Anastomotic recurrence of oesophageal squamous cell carcinoma after transthoracic oesophagectomy. , 2003, The European journal of surgery = Acta chirurgica.

[2]  K. Cheng,et al.  Classification of adenocarcinoma of the oesophagogastric junction , 1999, The British journal of surgery.

[3]  Y. Kodera,et al.  Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert's classification applied to 177 cases resected at a single institution. , 1999, Journal of the American College of Surgeons.

[4]  T. Sano,et al.  Left thoraco-abdominal approach (LT) compared with abdominal and transhiatal approach (AT) for cardia or sub-cardia cancer. Results of a surgical randomized controlled trial (JCOG9502). , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  Cynthia Levy,et al.  Ursodeoxycholic acid and long-term survival in primary biliary cirrhosis. , 2004, The American journal of gastroenterology.

[6]  M. Brennan,et al.  Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach. , 1997, Annals of surgery.

[7]  A. Hölscher,et al.  Topographical distribution of lymph node metastasis in adenocarcinoma of the gastroesophageal junction. , 2002, Hepato-gastroenterology.

[8]  T. Dehn,et al.  Ratio of invaded to removed lymph nodes as a prognostic factor in adenocarcinoma of the distal esophagus and esophagogastric junction. , 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[9]  J. Wong,et al.  Local recurrences after subtotal esophagectomy for squamous cell carcinoma. , 1987, Annals of surgery.

[10]  J. Wong,et al.  Shrinkage of the Esophagus after Resection for Carcinoma , 1986, Annals of surgery.

[11]  D. Papachristou,et al.  Anastomotic recurrence in the oesophagus complicating gastrectomy for adenocarcinoma of the stomach , 1979, The British journal of surgery.

[12]  M. Kattan,et al.  Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  F. Ellis,et al.  Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria. , 1997, The Journal of thoracic and cardiovascular surgery.

[14]  S. Ashley,et al.  Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? , 2004, Journal of the American College of Surgeons.

[15]  Cornelis J H van de Velde,et al.  Validation of a nomogram for predicting disease‐specific survival after an R0 resection for gastric carcinoma , 2005, Cancer.

[16]  R. Koller,et al.  Prognostic factors in adenocarcinoma of the cardia. , 1995, American journal of surgery.

[17]  M. Bennett,et al.  The pattern of recurrence of adenocarcinoma of the oesophago-gastric junction , 2002, British Journal of Cancer.

[18]  S. Law,et al.  The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. , 1998, American journal of surgery.

[19]  D. Siegmund,et al.  Maximally Selected Chi Square Statistics , 1982 .

[20]  W. Grigioni,et al.  Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. , 2001, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[21]  I. Ninomiya,et al.  Lymph node metastasis and surgical management of gastric cancer invading the esophagus. , 1995, Hepato-gastroenterology.

[22]  M. Feith,et al.  Adenocarcinoma of the Esophagogastric Junction: Results of Surgical Therapy Based on Anatomical/Topographic Classification in 1,002 Consecutive Patients , 2000, Annals of surgery.

[23]  J. Ajani,et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.

[24]  Ahmed Hassan Awadallah,et al.  Results of Surgical Therapy of Adenocarcinomas of the Esophagogastric Junction According to a Standardized Surgical Resection Technique , 2012, Digestive Surgery.

[25]  D. Wattchow,et al.  Positive proximal resection margins after resection for carcinoma of the oesophagus and stomach: effect on survival and symptom recurrence. , 1996, The Australian and New Zealand journal of surgery.

[26]  Jeremy L. Ward,et al.  Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study , 2003, BMJ : British Medical Journal.

[27]  C. Wastell,et al.  The right approach to carcinoma of the cardia: preliminary results. , 1992, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[28]  N. Agnanti,et al.  Histologically positive esophageal margin in the surgical treatment of gastric cancer. , 1980, American journal of surgery.

[29]  N. Altorki,et al.  En bloc esophagectomy improves survival for stage III esophageal cancer. , 1997, The Journal of thoracic and cardiovascular surgery.

[30]  M. Brennan,et al.  Extended lymphadenectomy is associated with a survival benefit for node-negative gastric cancer , 1998, Journal of Gastrointestinal Surgery.

[31]  P. D. De Leyn,et al.  Three-field lymphadenectomy and pattern of lymph node spread in T3 adenocarcinoma of the distal esophagus and the gastro-esophageal junction. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[32]  C. Mariette,et al.  Surgical management of and long‐term survival after adenocarcinoma of the cardia , 2002, The British journal of surgery.

[33]  A. Di Giorgio,et al.  Surgical treatment of adenocarcinoma of the cardia. , 1992, Surgery.

[34]  M. Luostarinen,et al.  Fate of Patients with Adenocarcinoma of the Esophagus and the Esophagogastric Junction: A Population-Based Analysis , 2004, American Journal of Gastroenterology.

[35]  Y. Kakeji,et al.  Margins of resection of the esophagus for gastric cancer with esophageal invasion. , 1995, Hepato-gastroenterology.

[36]  C. Mariette,et al.  Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction. , 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[37]  A. Neugut,et al.  Epidemiology of upper gastrointestinal malignancies. , 2004, Seminars in oncology.

[38]  L. Friedman,et al.  Adenocarcinoma of the Esophagogastric Junction , 1999, Digestive Diseases.

[39]  D. Klimstra,et al.  Effect of microscopic resection line disease on gastric cancer survival , 1998, Journal of Gastrointestinal Surgery.

[40]  V. Rusch,et al.  The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma. , 2004, Journal of the American College of Surgeons.

[41]  Paul Fockens,et al.  Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. , 2002, The New England journal of medicine.

[42]  H. Taniguchi,et al.  Resection margin in patients with gastric cancer associated with esophageal invasion: Clinicopathological study , 1993, Journal of surgical oncology.

[43]  M. Bennett,et al.  The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. , 2001, Surgery.

[44]  H. Sawada,et al.  Characteristics and clinical outcome of proximal-third gastric cancer. , 1998, Journal of the American College of Surgeons.

[45]  F. Borchard,et al.  Cancer of the Distal Esophagus and Cardia: Incidence, Tumorous Infiltration, and Metastatic Spread , 1986, Annals of surgery.

[46]  F. Bozzetti,et al.  Surgical treatment of gastric cancer invading the oesophagus. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[47]  J. Peters,et al.  Curative Resection for Esophageal Adenocarcinoma: Analysis Of 100 En Bloc Esophagectomies , 2001, Annals of surgery.